These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25376822)

  • 21. Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non-ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project.
    Yang N; Liu J; Liu J; Hao Y; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Zhou M; Xing Y; Zhao D;
    Am Heart J; 2019 Jun; 212():80-90. PubMed ID: 30981036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of current treatment practice and outcomes for in-patients with ST-segment elevation acute coronary syndrome in 31 provinces of China].
    Bridging the Gap on Coronary Heart Disease Secondary Prevention in China
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):440-5. PubMed ID: 21681279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing.
    Zhou Y; Yao X; Liu G; Jian W; Yip W
    BMC Health Serv Res; 2019 Jan; 19(1):43. PubMed ID: 30658628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome.
    Hao Y; Liu J; Liu J; Smith SC; Huo Y; Fonarow GC; Ma C; Ge J; Taubert KA; Morgan L; Guo Y; Zhang Q; Wang W; Zhao D;
    Am Heart J; 2016 Sep; 179():107-15. PubMed ID: 27595685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receipt of cardiac medications upon discharge among men and women with acute coronary syndrome and nonobstructive coronary artery disease.
    Ramanath VS; Armstrong DF; Grzybowski M; Rahnama-Mohagdam S; Tamhane UU; Gordon K; Froehlich JB; Eagle KA; Jackson EA
    Clin Cardiol; 2010 Jan; 33(1):36-41. PubMed ID: 20063300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.
    Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [First Moscow "snapshot" register of acute coronary syndromes: characteristics of patients, management and outcomes during hospitalization].
    Érlikh AD; Matskeplishvili ST; Gratsianskiĭ NA; Buziashvili IuI
    Kardiologiia; 2013; 53(12):4-13. PubMed ID: 24800475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-hospital cardiac arrest in acute coronary syndromes: insights from the global registry of acute coronary events and the canadian registry of acute coronary events.
    Li Q; Goodman SG; Yan RT; Gore JM; Polasek P; Lai K; Baer C; Goldberg RJ; Pinter A; Ahmad K; Kornder JM; Yan AT;
    Cardiology; 2013; 126(1):27-34. PubMed ID: 23860213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of adherence to composite therapy after acute coronary syndromes.
    Stabile E; Franzese M; Chianese S; Alfani A; Gerardi D; Colaiori I; Annunziata M; Nappi P; Scalise M; Di Serafino L; Puzone B; Avvedimento M; Leone A; Ilardi F; Piccolo R; Franzone A; Cirillo P; Morisco C; Trimarco B; Esposito G
    J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):645-651. PubMed ID: 33966020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.
    Toleva O; Westerhout CM; Senaratne MP; Bode C; Lindroos M; Sulimov VA; Montalescot G; Newby LK; Giugliano RP; Van de Werf F; Armstrong PW
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):934-42. PubMed ID: 24976083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).
    Pavlides G; Drossinos V; Dafni C; Altsitzoglou P; Antoniadis A; Manolis AS; Tsioufis C; Goudevenos I; Kochiadakis G; Alexopoulos D
    Hellenic J Cardiol; 2013; 54(4):255-63. PubMed ID: 23912917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of blood pressure control rate and antihypertensive drug use in the elderly coronary heart disease patients with diabetes mellitus and hypertension].
    Liang D; Li X; Wang L; Xu H; Tuo X; Jian Z
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(33):2709-14. PubMed ID: 26711829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to guidelines for pharmacological treatment of young adults with myocardial infarction in Poland: Data from Polish Registry of Acute Coronary Syndromes (PL-ACS).
    Lisowska A; Makarewicz-Wujec M; Dworakowska AM; Kozłowska-Wojciechowska M
    J Clin Pharm Ther; 2019 Jun; 44(3):471-478. PubMed ID: 30763467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand.
    Parkin L; Quon J; Sharples K; Barson D; Dummer J
    Respirology; 2020 Feb; 25(2):173-182. PubMed ID: 31401813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.
    Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Gori T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Thalmeier A; Löw A; Holdt L; Teupser D; Ince H; Felix SB; Parma R; Malek L; Horstkotte J; Baylacher M; Schwinger R; Rieber J; Mudra H; Hausleiter J; Huber K; Neumann FJ; Koltowski L; Huczek Z; Mehilli J; Massberg S;
    Thromb Haemost; 2017 Jan; 117(1):188-195. PubMed ID: 27652610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.
    Bezin J; Groenwold RH; Ali MS; Lassalle R; Robinson P; de Boer A; Moore N; Klungel OH; Pariente A
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):285-293. PubMed ID: 28124399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.